Meridian Investment Counsel Inc. Boosts Holdings in Gilead Sciences, Inc. (GILD)

Meridian Investment Counsel Inc. Boosts Holdings in Gilead Sciences, Inc. (GILD)

The Becker Capital Management Inc holds 687,979 shares with $48.70M value, up from 546,419 last quarter. Mcdonald's now has $138.37 billion valuation.

The stock increased 0.42% or $0.23 during the last trading session, reaching $54.08. About 1.55 million shares traded. (NASDAQ:RAVE) has declined 50.12% since December 7, 2016 and is downtrending. It has outperformed by 0.96% the S&P500.

Wealth Enhancement Advisory Services Llc increased Gilead Sciences Inc (GILD) stake by 242.1% reported in 2017Q2 SEC filing. During the same quarter in the previous year, the business posted $2.75 EPS. sell-side analysts predict that Gilead Sciences, Inc. will post 8.53 earnings per share for the current fiscal year. Gilead Sciences reported earnings per share of $3.03 during the same quarter last year, which suggests a negative year-over-year growth rate of 32.7%.

Investors may be interested in viewing the Gross Margin score on shares of Gilead Sciences, Inc.

The stock decreased 1.23% or $0.74 during the last trading session, reaching $59.2. About 2.62M shares traded.

More news: Concentrate on the Analyst's Move:: H&R Block, Inc. (HRB)

Gilead Sciences (NASDAQ:GILD) last issued its earnings results on Thursday, October 26th. It has underperformed by 38.50% the S&P500. Virginia Retirement System Et Al reported 355,200 shares or 0.31% of all its holdings. Gregg Alton has seen steady activity on the sell side, and on December 1, 2017, executed an option to sell 15000 shares.

Investors sentiment increased to 1.39 in Q2 2017. Its up 0.33, from 1.3 in 2017Q1. Burns J W And Commerce New York, a New York-based fund reported 29,146 shares. 36 funds opened positions while 109 raised stakes. Stephens Ar stated it has 0.02% of its portfolio in Tyler Technologies, Inc. Qcm Cayman Limited has invested 0.54% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Segall Bryant And Hamill Limited Liability accumulated 75,592 shares. Curbstone Financial Mgmt reported 13,970 shares. Cutter & Brokerage holds 0.61% or 21,895 shares. Da Davidson And invested in 0% or 100 shares. First Savings Bank Of Omaha has invested 0.01% in Gilead Sciences, Inc. (NYSE:HON) for 5,152 shares. TFS Capital LLC now owns 6,791 shares of the biopharmaceutical company's stock valued at $461,000 after acquiring an additional 97 shares during the period. (NasdaqGS:GILD) is 0.204932. This number is calculated by dividing net income after tax by the company's total assets. (NYSE:HON). Ent Fin invested in 923 shares. Moreover, Main Street Rech Ltd Liability Corp has 0.07% invested in Gilead Sciences, Inc.

Among 21 analysts covering Honeywell International Inc. Therefore 92% are positive. Jazz Pharmaceuticals had 66 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray with "Buy" on Friday, July 14. CREDIT SUISSE AG/ also announced decreased position in LendingClub Corporation (LC) during the quarter. Oppenheimer maintained 2U, Inc. Citigroup initiated the stock with "Buy" rating in Thursday, February 25 report. (NASDAQ:GILD) has "Outperform" rating given on Wednesday, February 3 by RBC Capital Markets. The rating was maintained by Morgan Stanley with "Overweight" on Wednesday, August 16. The company was maintained on Tuesday, July 25 by Mizuho. On Tuesday, September 27 the stock rating was downgraded by Leerink Swann to "Mkt Perform".

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1.

A number of other institutional investors have also bought and sold shares of GILD. Toronto Dominion Bank raised its position in shares of Gilead Sciences by 46.0% in the first quarter. 536.45 million shares or 0.05% more from 536.18 million shares in 2017Q1 were reported. Private Cap Advisors holds 12,457 shares or 0.29% of its portfolio. Gateway Invest Advisers Ltd Liability Company stated it has 0.52% in Gilead Sciences, Inc. That transaction by Vanguard took place on September 30, 2017, the same day Fmr Llc purchased an additional 4.67 million shares in GILD to bring its total stake to 27.71 million. Reliance Tru Of Delaware reported 0.08% of its portfolio in Gilead Sciences, Inc. Stockholders of record on Friday, December 15th will be paid a dividend of $0.52 per share. Finally, HighPoint Advisor Group LLC boosted its stake in shares of Gilead Sciences by 0.5% in the third quarter. Kopp Investment Advisors Llc, a Minnesota-based fund reported 55,326 shares. Hills Bancorporation Trust holds 0.42% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Pitcairn invested 0.31% in Gilead Sciences, Inc. (NASDAQ:GILD) for 194,665 shares. Tortoise Investment Mngmt Lc owns 2,260 shares or 0.05% of their U.S. portfolio. Winslow Evans And Crocker reported 1,752 shares or 0% of all its holdings. Lawson Kroeker Management Ne holds 120,922 shares or 2.87% of its portfolio. Howard Hughes Med Institute invested in 5,966 shares. Berenberg Bank set a $96.00 price target on Gilead Sciences and gave the stock a "buy" rating in a research report on Thursday, October 19th. Therefore 33% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned "Hold" rating on Tuesday, May 30 by Maxim Group. San Francisco Sentry Grp Incorporated (Ca) holds 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD). 13,149 are held by Strategic Advsrs Limited Liability Corporation. The stock appeared -15.04% downward to its 52-week high and 14.95% above its 52-week low.

Related Articles